- Home
- RYTM vs NAVN Comparison
RYTM vs NAVN Comparison
Compare RYTM & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- NAVN
- Stock Information
- Founded
- RYTM 2008
- NAVN 2015
- Country
- RYTM United States
- NAVN United States
- Employees
- RYTM N/A
- NAVN N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- NAVN Computer Software: Prepackaged Software
- Sector
- RYTM Health Care
- NAVN Technology
- Exchange
- RYTM Nasdaq
- NAVN Nasdaq
- Market Cap
- RYTM 6.4B
- NAVN 5.3B
- IPO Year
- RYTM 2017
- NAVN 2025
- Fundamental
- Price
- RYTM $98.54
- NAVN $18.04
- Analyst Decision
- RYTM Strong Buy
- NAVN
- Analyst Count
- RYTM 12
- NAVN 0
- Target Price
- RYTM $117.00
- NAVN N/A
- AVG Volume (30 Days)
- RYTM 629.6K
- NAVN 4.4M
- Earning Date
- RYTM 11-04-2025
- NAVN 11-25-2025
- Dividend Yield
- RYTM N/A
- NAVN N/A
- EPS Growth
- RYTM N/A
- NAVN N/A
- EPS
- RYTM N/A
- NAVN N/A
- Revenue
- RYTM $174,334,000.00
- NAVN $612,523,000.00
- Revenue This Year
- RYTM $46.10
- NAVN N/A
- Revenue Next Year
- RYTM $63.02
- NAVN N/A
- P/E Ratio
- RYTM N/A
- NAVN N/A
- Revenue Growth
- RYTM 54.92
- NAVN 33.46
- 52 Week Low
- RYTM $45.91
- NAVN $16.01
- 52 Week High
- RYTM $116.00
- NAVN $22.75
- Technical
- Relative Strength Index (RSI)
- RYTM 39.87
- NAVN N/A
- Support Level
- RYTM $95.27
- NAVN N/A
- Resistance Level
- RYTM $102.20
- NAVN N/A
- Average True Range (ATR)
- RYTM 4.86
- NAVN 0.00
- MACD
- RYTM -1.75
- NAVN 0.00
- Stochastic Oscillator
- RYTM 17.51
- NAVN 0.00
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.